Sage sags on phase 3 epilepsy med failure 9:24 AM health No comments Sage sags on phase 3 epilepsy med failure FierceBiotech Sage scraps seizure drug study after trial failure, shares slump Nasdaq UPDATE 2-Sage's seizure drug fails key trial, shares slump Times of IndiaFull coverage Share It Facebook Twitter LinkedIn BLOG AUTHOR Please add Follow him @ Linkedin | Instagram | Twitter
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.